Correlation Between Fubon MSCI and OBI Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fubon MSCI and OBI Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fubon MSCI and OBI Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fubon MSCI Taiwan and OBI Pharma, you can compare the effects of market volatilities on Fubon MSCI and OBI Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fubon MSCI with a short position of OBI Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fubon MSCI and OBI Pharma.

Diversification Opportunities for Fubon MSCI and OBI Pharma

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Fubon and OBI is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Fubon MSCI Taiwan and OBI Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OBI Pharma and Fubon MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fubon MSCI Taiwan are associated (or correlated) with OBI Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OBI Pharma has no effect on the direction of Fubon MSCI i.e., Fubon MSCI and OBI Pharma go up and down completely randomly.

Pair Corralation between Fubon MSCI and OBI Pharma

Assuming the 90 days trading horizon Fubon MSCI Taiwan is expected to generate 0.71 times more return on investment than OBI Pharma. However, Fubon MSCI Taiwan is 1.4 times less risky than OBI Pharma. It trades about 0.1 of its potential returns per unit of risk. OBI Pharma is currently generating about -0.03 per unit of risk. If you would invest  9,120  in Fubon MSCI Taiwan on December 2, 2024 and sell it today you would earn a total of  5,205  from holding Fubon MSCI Taiwan or generate 57.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Fubon MSCI Taiwan  vs.  OBI Pharma

 Performance 
       Timeline  
Fubon MSCI Taiwan 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Fubon MSCI Taiwan are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Fubon MSCI is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
OBI Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days OBI Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, OBI Pharma is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Fubon MSCI and OBI Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fubon MSCI and OBI Pharma

The main advantage of trading using opposite Fubon MSCI and OBI Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fubon MSCI position performs unexpectedly, OBI Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OBI Pharma will offset losses from the drop in OBI Pharma's long position.
The idea behind Fubon MSCI Taiwan and OBI Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas